Literature DB >> 15989996

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

Renaud de Crevoisier1, Susan L Tucker, Lei Dong, Radhe Mohan, Rex Cheung, James D Cox, Deborah A Kuban.   

Abstract

PURPOSE: To retrospectively test the hypothesis that rectal distension on the planning computed tomography (CT) scan is associated with an increased risk of biochemical and local failure among patients irradiated for prostate carcinoma when a daily repositioning technique based on direct prostate-organ localization is not used. METHODS AND MATERIALS: This study included 127 patients who received definitive three-dimensional conformal radiotherapy for prostate cancer to a total dose of 78 Gy at The University of Texas M. D. Anderson Cancer Center. Rectal distension was assessed by calculation of the average cross-sectional rectal area (CSA; defined as the rectal volume divided by length) and measuring three rectal diameters on the planning CT. The impact of rectal distension on biochemical control, 2-year prostate biopsy results, and incidence of Grade 2 or greater late rectal bleeding was assessed.
RESULTS: The incidence of biochemical failure was significantly higher among patients with distended rectums (CSA >11.2 cm(2)) on the planning CT scan (p = 0.0009, log-rank test). Multivariate analysis indicates that rectal distension and high-risk disease are independent risk factors for biochemical failure, with hazard ratios of 3.89 (95% C.I. 1.58 to 9.56, p = 0.003) and 2.45 (95% C.I. 1.18 to 5.08, p = 0.016), respectively. The probability of residual tumor without evidence of radiation treatment (as scored by the pathologist) increased significantly with rectal distension (p = 0.010, logistic analysis), and a lower incidence of Grade 2 or greater late rectal bleeding within 2 years was simultaneously observed with higher CSA values (p = 0.031, logistic analysis).
CONCLUSIONS: We found strong evidence that rectal distension on the treatment-planning CT scan decreased the probability of biochemical control, local control, and rectal toxicity in patients who were treated without daily image-guided prostate localization, presumably because of geographic misses. Therefore, an empty rectum is warranted at the time of simulation. These results also emphasize the need for image-guided radiotherapy to improve local control in irradiating prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15989996     DOI: 10.1016/j.ijrobp.2004.11.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  85 in total

Review 1.  A review of image-guided radiotherapy.

Authors:  George T Y Chen; Gregory C Sharp; Shinichiro Mori
Journal:  Radiol Phys Technol       Date:  2008-12-16

Review 2.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

3.  Which bowel preparation is best? Comparison of a high-fibre diet leaflet, daily microenema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on planned target volume shifts due to rectal distension.

Authors:  S Yahya; A Zarkar; E Southgate; P Nightingale; G Webster
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

4.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

Review 5.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

6.  Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.

Authors:  Kliton Jorgo; Péter Ágoston; Tibor Major; Zoltán Takácsi-Nagy; Csaba Polgár
Journal:  Strahlenther Onkol       Date:  2017-02-02       Impact factor: 3.621

7.  Changes in rectal volume and prostate localization due to placement of a rectum-emptying tube.

Authors:  Hiroshi Fuji; Shigeyuki Murayama; Masashi Niwakawa; Raizou Yamaguchi; Ryou Yamashita; Takashi Matsui; Haruo Yamashita; Tetsuo Nishimura; Kenichi Tobisu
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

8.  Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial.

Authors:  Annemarie M den Harder; Carla H van Gils; Alexis N T J Kotte; Marco van Vulpen; Irene M Lips
Journal:  Strahlenther Onkol       Date:  2014-04-24       Impact factor: 3.621

9.  Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study).

Authors:  Krista Dawdy; Katija Bonin; Steve Russell; Agnes Ryzynski; Tamara Harth; Christopher Townsend; Stanley Liu; William Chu; Patrick Cheung; Hans Chung; Gerard Morton; Danny Vesprini; Andrew Loblaw; Xingshan Cao; Ewa Szumacher
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

Review 10.  Systematic review of hypofractionated radiation therapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Nitin Ohri; Timothy N Showalter; Adam P Dicker; Robert B Den
Journal:  Cancer Treat Rev       Date:  2013-03-01       Impact factor: 12.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.